Table 1.
Reference | Year | Single- or Multi-Institutional | Type of Study | Number of Patients Included | Number of Patients with pmGC and CRS + HIPEC |
---|---|---|---|---|---|
Fujimoto [29] | 1988 | single | PCS | 15 | 9 |
Fujimoto [30] | 1997 | single | RCS | 48 | 30 |
Chen [31] | 1997 | single | RCS | 42 | 6 |
Sayag-Beaujard [32] | 1999 | single | pCTII | 83 | 18 |
Loggie [33] | 2000 | single | pCTII | 84 | 22 |
Glehen [34] | 2004 | single | RCS | 49 | 21 |
Yonemura [35] | 2005 | single | RCS | 107 | 42 |
Kusamura [36] | 2006 | single | RCS | 209 | 12 |
Roviello [37] | 2006 | single | RCS | 59 | 6 |
Scaringi [38] | 2008 | single | RCS | 37 | 26 |
Yang [39] | 2009 | single | RCS | 21 | 12 |
Piso [40] | 2009 | single | RCS | 37 | 11 |
Yang [41] | 2010 | single | pCTII | 28 | 28 |
Li [42] | 2010 | single | RCS | 128 | 10 |
Glehen [43] | 2010 | multiple | RCS | 159 | 147 |
Yang [44] | 2011 | single | RCT | 68 | 34 |
Cotte [45] | 2011 | single | pCTI | 12 | 12 |
Mizumoto [46] | 2012 | single | RCS | 250 | 16 |
Wu [47] | 2013 | single | RCS | 62 | 32 |
Yarema [48] | 2014 | single | RCS | 98 | 20 |
Tabrizian [49] | 2014 | single | RCS | 170 | 12 |
Rudloff [50] | 2014 | single | RCT | 17 | 9 |
Magge [51] | 2014 | single | RCS | 23 | 23 |
Levine [52] | 2014 | single | RCS | 1000 | 46 |
Kim [53] | 2014 | single | RCS | 112 | 9 |
Königsrainer [54] | 2014 | single | RCS | 18 | 13 |
Graziosi [55] | 2014 | single | RCS | 36 | 15 |
Polanco [56] | 2015 | single | PCS | 370 | 24 |
Desantis [57] | 2015 | single | RCS | 356 | 14 |
Wu [58] | 2016 | single | RCS | 50 | 50 |
Kopanakis [59] | 2017 | single | RCS | 14 | 14 |
Rihuete Caro [60] | 2018 | single | RCS | 35 | 32 |
Montori [61] | 2018 | single | RCS | 150 | 26 |
Yarema [62] | 2019 | multiple | RCS | 117 | 70 |
Solomon [63] | 2019 | single | RCS | 268 | 18 |
Rau [4] | 2019 | single | RCS | 88 | 58 |
Manzanedo [64] | 2019 | multiple | RCS | 88 | 84 |
Kimbrough [65] | 2019 | multiple | RCS | 28 | 28 |
Hotopp [66] | 2019 | single | RCS | 26 | 26 |
Bonnot [17] | 2019 | multiple | RCS-PSm | 275 | 180 |
Braeuer [67] | 2020 | single | RCS | 109 | 37 |
Koemans [68] | 2021 | single | pCT I–II | 25 | 23 |
PCS: prospective cohort study; RCS: retrospective cohort study; RCT: randomized controlled trial; pCTI: prospective clinical trial phase I; pCTII: prospective clinical trial phase II; PSm: propensity score matched.